- Home
- UTSI vs TPST Comparison
UTSI vs TPST Comparison
Compare UTSI & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTSI
- TPST
- Stock Information
- Founded
- UTSI 1991
- TPST 2011
- Country
- UTSI China
- TPST United States
- Employees
- UTSI N/A
- TPST N/A
- Industry
- UTSI Telecommunications Equipment
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- UTSI Telecommunications
- TPST Health Care
- Exchange
- UTSI Nasdaq
- TPST Nasdaq
- Market Cap
- UTSI 25.4M
- TPST 27.2M
- IPO Year
- UTSI 2000
- TPST N/A
- Fundamental
- Price
- UTSI $2.45
- TPST $0.89
- Analyst Decision
- UTSI
- TPST Strong Buy
- Analyst Count
- UTSI 0
- TPST 4
- Target Price
- UTSI N/A
- TPST $20.00
- AVG Volume (30 Days)
- UTSI 5.4K
- TPST 3.3M
- Earning Date
- UTSI 09-05-2024
- TPST 11-12-2024
- Dividend Yield
- UTSI N/A
- TPST N/A
- EPS Growth
- UTSI N/A
- TPST N/A
- EPS
- UTSI N/A
- TPST N/A
- Revenue
- UTSI $14,958,000.00
- TPST N/A
- Revenue This Year
- UTSI N/A
- TPST N/A
- Revenue Next Year
- UTSI N/A
- TPST N/A
- P/E Ratio
- UTSI N/A
- TPST N/A
- Revenue Growth
- UTSI 14.41
- TPST N/A
- 52 Week Low
- UTSI $2.20
- TPST $0.83
- 52 Week High
- UTSI $3.70
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- UTSI 36.27
- TPST 34.45
- Support Level
- UTSI $2.50
- TPST $0.94
- Resistance Level
- UTSI $2.89
- TPST $1.16
- Average True Range (ATR)
- UTSI 0.19
- TPST 0.10
- MACD
- UTSI -0.04
- TPST 0.00
- Stochastic Oscillator
- UTSI 0.00
- TPST 15.50
About UTSI UTStarcom Holdings Corp.
UTStarcom Holdings Corp operates as a telecom infrastructure provider. It develops technology for bandwidth from cloud-based services, mobile, streaming, and other applications. The range of solutions is designed to expand and modernize telecommunications networks through smooth network system integration, lower operating costs, and increased broadband access. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. The company operates in China, India, Japan, Taiwan and other countries.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.